Ramos 2018.

Methods	Study design: multi‐centre, unknown blinding, parallel individual randomised controlled trial in unknown country Duration: 12 weeks Setting: not reported
Participants	Population: 20 adults recruited Baseline characteristics: % Male: 100 RM and 100 UC, Mean age: 77.0 RM and 76.63 UC, % White: not reported, % African: not reported, % LTOT: not reported, % Home oxygen: not reported, % Anxiety or depression: not reported, Baseline meds: not reported, FEV₁ (% mean): RM 48.75 and UC 42.81, FVC (% mean): not reported, FEV₁/FVC (% mean): not reported, Current smokers (n): not reported, GOLD stage: not reported, COPD exacerbations last 12 months: not reported, Hospitalisations in past 12 months: not reported Inclusion criteria: not reported Exclusion criteria: not reported
Interventions	Measurements taken at baseline and at end of study Treatment arms Telephone assistance for COPD
Outcomes	Primary outcomes: exacerbation rate, hospital admission, mortality Secondary outcomes: not reported
Notes	Funding: not reported Other identifier: not reported Other: only conference abstract available; pilot project